Nicox
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Sundesk Sophia Antipolis Emerald Square ...Phone Number
+33 497245300Website
www.nicox.comRevenue
$9.2 MillionStock Symbol
NICXFIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Nicox
Nicox is an international ophthalmology company founded in 1996 and headquartered in Sophia Antipolis, France. The company specializes in developing innovative solutions for vision maintenance and ocular health improvement. Nicox focuses on research and development of treatments for conditions such as open-angle glaucoma, ocular hypertension, and dry eye disease. The company has developed products including VYZULTA for glaucoma and ZERVIATE for allergic conjunctivitis, which are licensed to partners in various global markets. Nicox maintains operations across multiple locations in Europe and North America, with a strong focus on scientific research in ophthalmology. The company is publicly traded on Euronext Paris and is included in several healthcare and pharmaceutical indices.Explore more
Nicox Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nicox your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Nicox has new funding data
Nicox, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Nicox is spiking on competitors!
Click to see if Nicox had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Nicox
Website visits: Recent activity has been detected on your website
Check if Nicox has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Nicox recently announced quarterly report
Product Launch: Get notified when Nicox launches new products
Recommended Actions
Reach out to Masked Content who joined Nicox as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Nicox is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nicox is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nicox.
Nicox financials insights
Gather financial insights about Nicox, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Share Placement
$13.6M
2020
Share Placement
$18.2M
2021
Share Placement
$16.9M
2022
Share Placement
$10M
Nicox Tech Stack
A closer look at the technologies used by Nicox
See more technologies
Most Recent Scoops
Award
Earnings, Finance
Funding
Funding
Person-Based
Person-Based
Person-Based
Nicox News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nicox
Sign Up For FreeTo access detailed company insights
Nicox is an international ophthalmology company founded in 1996 and headquartered in Sophia Antipolis, France. The company specializes in developing innovative solutions for vision maintenance and ocular health improvement. Nicox focuses on research and development of treatments for conditions such as open-angle glaucoma, ocular hypertension, and d... Read More
